Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 834852, 4 pages
http://dx.doi.org/10.1155/2012/834852
Clinical Study

Clinical Behavior in Metastatic Brain Disease Is Not Influenced by the Immunological Defense Mediated by CD57+ NK-Cells

1Laboratory of Experimental Neuro-Oncology, Neuroscience Research Unit, Puerta de Hierro Hospital, Autonomous University, 28222 Madrid, Spain
2Neurosurgical Service, Puerta de Hierro Hospital, Autonomous University, 28222 Madrid, Spain
3Department of Pathology, Central Defense Hospital, 28047 Madrid, Spain

Received 21 April 2011; Revised 22 May 2011; Accepted 24 May 2011

Academic Editor: Russell Lonser

Copyright © 2012 J. Vaquero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Tranchieri, “Biology of human natural killer cells,” Advances in Immunology, vol. 47, pp. 187–376, 1989. View at Google Scholar · View at Scopus
  2. G. Trinchieri and B. Perussia, “Human natural killer cells: biologic and pathologic aspects,” Laboratory Investigation, vol. 50, no. 5, pp. 489–513, 1984. View at Google Scholar · View at Scopus
  3. Y. Kashii, R. Giorda, R. B. Herberman, T. L. Whiteside, and N. L. Vujanovic, “Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells,” Journal of Immunology, vol. 163, no. 10, pp. 5358–5366, 1999. View at Google Scholar · View at Scopus
  4. V. Screpanti, R. P. A. Wallin, H. G. Ljunggren, and A. Grandien, “A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells,” Journal of Immunology, vol. 167, no. 4, pp. 2068–2073, 2001. View at Google Scholar · View at Scopus
  5. N. L. Vujanovic, “Role of TNF family ligands in antitumor activity of natural killer cells,” International Reviews of Immunology, vol. 20, no. 3-4, pp. 415–437, 2001. View at Google Scholar · View at Scopus
  6. H. S. Warren and M. J. Smyth, “NK cells and apoptosis,” Immunology and Cell Biology, vol. 77, no. 1, pp. 64–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ishigami, S. Natsugoe, K. Tokuda et al., “Prognostic value of intratumoral natural killer cells in gastric carcinoma,” Cancer, vol. 88, no. 3, pp. 577–583, 2000. View at Google Scholar · View at Scopus
  8. F. R. Villegas, S. Coca, V. G. Villarrubia et al., “Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer,” Lung Cancer, vol. 35, no. 1, pp. 23–28, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Vaquero, M. Zurita, and S. Oya, “Immune-cell system provides the development of extraneural tumors in the ethyl-nitrosourea model of neurocarcinogenesis,” Cancer Letters, vol. 123, no. 1, pp. 95–98, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Vaquero, M. Zurita, C. Aguayo, and S. Coca, “Apoptosis is not correlated with the presence of CD57+ NK-cells in brain metastases,” Acta Neurochirurgica, vol. 145, no. 9, pp. 773–776, 2003. View at Publisher · View at Google Scholar · View at Scopus